Article

Trial compares wavefront-optimized versus wavefront-guided sub-Bowman's keratomileusis

Las Vegas-Accurate refractive outcomes are achieved when sub-Bowman's keratomileusis (SBK) is performed with either a wavefront-optimized (WaveLight Technologie AG) or wavefront-guided (CustomCornea, Alcon Laboratories) ablation platform. The wavefront-guided procedure, however, appears to have a benefit for inducing less spherical aberration, according to analysis of 3-month results from a prospective contralateral-eye study reported by Dan Tran, MD, at the refractive surgery subspecialty day during the American Academy of Ophthalmology annual meeting here.

"Further investigation is needed, but our preliminary data suggest the benefit of the wavefront-guided procedure may be important in patients with larger pupils," said Dr. Tran, medical director, Coastal Vision Medical Group, Newport Beach, CA.

The single-surgeon study was designed to compare the objective and subjective visual outcomes using the different laser platforms. Dominant eyes of 19 patients were randomly assigned to one of the two procedures, and the alternate surgery was performed in the fellow eye.

HOAs were analyzed based on 6.0-mm dilated scans. Preoperatively mean HOA RMS was about 0.40 µm in both groups. At 3 months, mean HOA RMS was essentially unchanged after wavefront-guided treatment and increased slightly (about 0.1 µm) after wavefront-optimized treatment.

Good control of HOAs

"Due to the small sample size, differences from baseline were not statistically significant. In general, however, there was good control of HOA induction with both procedures," Dr. Tran said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.